S2213
|
SWOG
|
A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S2302
|
SWOG
|
Pragmatica - Lung: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) plus Pembrolizumab (MK-3475; NSC 776864) versus Standard of Care (SOC) for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S2303
|
SWOG
|
Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS ≥ 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S2308
|
SWOG
|
Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S2312
|
SWOG
|
A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S2408
|
SWOG
|
A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
S2414
|
SWOG
|
Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non-Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S9910
|
SWOG
|
Leukemia Centralized Reference Laboratories and Tissue Repositories Ancillary
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S9925
|
SWOG
|
Lung Cancer Specimen Repository Protocol Ancillary
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
SCUSF-0901
|
COG
|
SCUSF 0901 [ACCL0922] A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
|
Pediatric CIRB
|
Available to Open
|
|